DMD and Duchenne muscular dystrophy: This is not enough to significantly improve the quality of life of dystrophin deficient animals that still display the hallmarks of DMD—intense degeneration, inflammation, and calcium dysregulation; however, this approach, and the reduction of fibrosis can be used as an adjunctive therapy to maintain a sufficient amount of target muscle that may be available for therapy and repair.